Literature DB >> 6036419

The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

S H Ferreira, J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6036419      PMCID： PMC1557274          DOI： 10.1111/j.1476-5381.1967.tb02148.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  13 in total

Review 1.  FORMATION AND DESTRUCTION OF PLASMA KININS.

Authors:  J C FASCIOLO
Journal:  Acta Physiol Lat Am       Date:  1964

2.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

3.  RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME.

Authors:  J A OATES; K MELMON; A SJOERDSMA; L GILLESPIE; D T MASON
Journal:  Lancet       Date:  1964-03-07       Impact factor: 79.321

4.  AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN.

Authors:  D A MCCARTHY; D E POTTER; E D NICOLAIDES
Journal:  J Pharmacol Exp Ther       Date:  1965-04       Impact factor: 4.030

5.  A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin.

Authors:  E STURMER; B BERDE
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

6.  Bradykinin and cardiovascular system: estimation of half-life.

Authors:  K SAAMELI; T K ESKES
Journal:  Am J Physiol       Date:  1962-08

7.  5-hydroxyindoles and kinins in the carcinoid and dumping syndromes.

Authors:  I J Zeitlin; A N Smith
Journal:  Lancet       Date:  1966-11-05       Impact factor: 79.321

8.  The detection and estimation of bradykinin in the circulating blood.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-03

9.  [On the inactivation of eledoisin and physalaemin by whole blood and tissue homogenates of several vertebrates].

Authors:  M B Nobili
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-11

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  43 in total

1.  Clinical significance of bradykinin liberation during cardiopulmonary bypass and its prevention by a kallikrein inhibitor.

Authors:  H Nagaoka; T Yamada; R Hatano; T Tsukuura; T Sakamoto
Journal:  Jpn J Surg       Date:  1975-12

2.  Inhibition of the pulmonary inactivation of prostaglandins in vivo by di-4-phloretin phosphate.

Authors:  D J Crutchley; P J Piper
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

3.  Catabolism of vasoactive polypeptides by perfused rat liver.

Authors:  D R Borges; E A Limãos; J L Prado; A C Camargo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

4.  Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

5.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

6.  History of the development of inhibitors of angiotensin I conversion.

Authors:  S H Ferreira
Journal:  Drugs       Date:  1985       Impact factor: 9.546

7.  Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.

Authors:  M Majima; K Nishiyama; Y Iguchi; K Yao; M Ogino; T Ohno; N Sunahara; K Katoh; N Tatemichi; Y Takei; M Katori
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

8.  Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme.

Authors:  F Dorer; J W Ryan; J M Stewart
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Bradykinin and functional vasodilatation in the salivary gland.

Authors:  S H Ferreira; L H Smaje
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.